Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACM-001.1 for Muscle Loss in Obesity During and After Semaglutide Therapy
NCT07101939Phase 2Recruiting
- Sponsor
- Actimed Therapeutics
- Start
- Jun 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of s-pindolol benzoate in Sarcopenia, sponsored by Actimed Therapeutics. Started Jun 2025; status: recruiting.
02
Drugs
s-pindolol benzoate
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT07101939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101939.